Betty Raman

MBBS DPhil FESC FRACP

Professor Betty Raman

Assoc Professor of Cardiovascular Medicine
NIHR South Central RRDN Cardiology Specialty Lead
Wellcome Career Development Award Fellow
RDM Cardiovascular Medicine EDI Champion

I am an academic cardiologist and a senior clinical research fellow with a special interest in advanced cardiovascular magnetic resonance (CMR) and its applications to inherited cardiovascular diseases.

I moved from Australia to Oxford in 2015, having completed my specialist clinical training in Cardiology (Fellow of the Royal Australasian College of Physicians) to undertake a DPhil in Hypertrophic Cardiomyopathy (HCM), an inherited cardiac disease which is the number one cause of sudden death in young adults and athletes. During my DPhil, we discovered a novel oxygen-sensitive magnetic resonance approach, which showed tremendous potential in predicting risk in HCM patients and has the ability to detect myocardial deoxygenation/hypoxia in other diseases non-invasively (and without contrast). This work and other research of mine were recognised for their novelty and awarded a number of prestigious national and international prizes (ESC, AHA, BSCMR young investigator/early career awards, finalists at BCS and SCMR). For my post-doc, I was awarded a British Heart Foundation CRE Transition Intermediate Clinical Research Fellowship in 2020 to carry on my research. in HCM . At the peak of the pandemic, I also led efforts to better understand the medium to long term effects of COVID-19 on the health of patients using MRI, CPET and other validated measures of mental, physical and cognitive health in a large multicentre study (C-MORE study).

As part of my current research focus in HCM, I seek to identify early sensitive markers of disease activity for early- and late-stage clinical trials and for prognostic risk stratification. In 2024, I was awarded the highly prestigious Wellcome Career Development Award to discover and validate novel sensitive measures of disease activity in early stage HCM and to identify individuals at risk of disease progression and poor clinical outcomes. My research focusing on early-stage HCM using cutting-edge CMR measures, holds the potential to significantly improve the management of this disease. By precisely characterising patients at an unprecedented level of detail, I hope to proactively identify those poised for disease progression, thus enabling timely interventions with novel disease modifying and gene therapies. Dynamic endpoints that detect rapid response will not only minimise prolonged exposure to uncharted therapies but also pave the way for swift therapeutic assessments. My research is also expected to significantly accelerate the transition of drugs from phase II to phase III trials, fostering patient confidence and participation in these crucial studies.

Recent publications

Could CT radiomics be the new frontier for myocardial tissue characterisation in cardiomyopathies?
Raman B. and Clarke N., (2025), Eur Heart J Cardiovasc Imaging
Assessing the impact of COmorbidities and Sociodemographic factors on Multiorgan Injury following COVID-19: rationale and protocol design of COSMIC, a UK multicentre observational study of COVID-negative controls.
Shergill S. et al, (2025), BMJ Open, 15
Large-scale genome-wide association analyses identify novel genetic loci and mechanisms in hypertrophic cardiomyopathy.
Tadros R. et al, (2025), Nat Genet, 57, 530 - 538
Post-Hospitalisation COVID-19 Rehabilitation (PHOSP-R): A randomised controlled trial of exercise-based rehabilitation.
Daynes E. et al, (2025), Eur Respir J
Multiparametric cardiovascular magnetic resonance evaluation of myocardial perfusion, oxygenation, and energetics in hypertrophic cardiomyopathy following cardiac myosin inhibitor therapy.
Finnigan LEM. et al, (2025), Eur Heart J Cardiovasc Imaging, 26
Myocardial disarray and fibrosis across hypertrophic cardiomyopathy stages associate with ECG markers of arrhythmic risk.
Ashkir Z. et al, (2025), Eur Heart J Cardiovasc Imaging, 26, 218 - 228
Long term health outcomes in people with diabetes 12 months after hospitalisation with COVID-19 in the UK: a prospective cohort study.
Gharibzadeh S. et al, (2025), EClinicalMedicine, 79
Demographic-Based Personalized Left Ventricular Hypertrophy Thresholds for Hypertrophic Cardiomyopathy Diagnosis.
Shiwani H. et al, (2024), J Am Coll Cardiol
Quantitative susceptibility mapping at 7 T in COVID-19: brainstem effects and outcome associations.
Rua C. et al, (2024), Brain, 147, 4121 - 4130
1H and 31P MR Spectroscopy to Assess Muscle Mitochondrial Dysfunction in Long COVID
Finnigan LEM. et al, (2024), Radiology, 313
1H and 31P MR Spectroscopy to Assess Muscle Mitochondrial Dysfunction in Long COVID.
Finnigan LEM. et al, (2024), Radiology, 313
Effects of software on myocardial T1 measurements: a 3 T multicentre single vendor phantom study
Atkinson D. et al, (2024)
Incidence of diabetes mellitus following hospitalisation for COVID-19 in the United Kingdom: A prospective observational study.
Tyrer F. et al, (2024), Diabetes Obes Metab
Diagnostic utility of electrocardiogram for screening of cardiac injury on cardiac magnetic resonance in post-hospitalised COVID-19 patients: a prospective multicenter study.
Samat AHA. et al, (2024), Int J Cardiol, 415
Clinical Significance of Myocardial Injury in Patients Hospitalized for COVID-19: A Prospective, Multicenter, Cohort Study.
Shiwani H. et al, (2024), JACC Cardiovasc Imaging, 17, 1320 - 1331
Feasibility of multiorgan risk prediction with routinely collected diagnostics: a prospective cohort study in the UK Biobank.
McCracken C. et al, (2024), BMJ Evid Based Med, 29, 313 - 323
1-year health outcomes associated with systemic corticosteroids for COVID-19: a longitudinal cohort study.
Leavy OC. et al, (2024), ERJ Open Res, 10
Cognitive and psychiatric symptom trajectories 2-3 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UK.
Taquet M. et al, (2024), Lancet Psychiatry, 11, 696 - 708
Differentiating Left Ventricular Remodeling in Aortic Stenosis From Systemic Hypertension.
Mahmod M. et al, (2024), Circ Cardiovasc Imaging, 17
CTEPH is an uncommon complication of COVID-19: UK national surveillance and observational screening cohort studies.
Reddy SA. et al, (2024), Eur Respir J
Mechanisms of ischaemia-induced arrhythmias in hypertrophic cardiomyopathy: a large-scale computational study.
Coleman JA. et al, (2024), Cardiovasc Res, 120, 914 - 926
Flow inefficiencies in non-obstructive HCM revealed by kinetic energy and hemodynamic forces on 4D-flow CMR.
Pola K. et al, (2024), Eur Heart J Imaging Methods Pract, 2
Hypertrophic cardiomyopathy detection with artificial intelligence electrocardiography in international cohorts: an external validation study.
Siontis KC. et al, (2024), Eur Heart J Digit Health, 5, 416 - 426
Long-term impact of COVID-19 hospitalisation among individuals with pre-existing airway diseases in the UK: a multicentre, longitudinal cohort study - PHOSP-COVID.
Elneima O. et al, (2024), ERJ Open Res, 10
Photon-counting computed tomography: 'one-stop shop' for coronary stenosis, inflammation, and myocardial assessment in ST-segment elevation acute coronary syndrome.
Kotronias RA. et al, (2024), Eur Heart J Cardiovasc Imaging, 25
Safety and Efficacy of Metabolic Modulation With Ninerafaxstat in Patients With Nonobstructive Hypertrophic Cardiomyopathy.
Maron MS. et al, (2024), J Am Coll Cardiol, 83, 2037 - 2048
Long COVID and cardiovascular disease: a prospective cohort study.
Lawson CA. et al, (2024), Open Heart, 11
The complexity of cardiovascular long COVID: where we are.
Gandhi RS. and Raman B., (2024), Cardiovasc Res
Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease.
Liew F. et al, (2024), Nat Immunol, 25, 607 - 621
Plasma steroid concentrations reflect acute disease severity and normalise during recovery in people hospitalised with COVID-19.
Devine K. et al, (2024), Clin Endocrinol (Oxf), 100, 317 - 327
Cohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID) study.
Elneima O. et al, (2024), Int J Epidemiol, 53
Electrophysiological mechanisms underlying T wave pseudonormalisation on stress ECGs in hypertrophic cardiomyopathy.
Coleman JA. et al, (2024), Comput Biol Med, 169
NHS Health Check attendance is associated with reduced multiorgan disease risk: a matched cohort study in the UK Biobank.
McCracken C. et al, (2024), BMC Med, 22
Association between SARC-F status and long-term physical function after COVID-19 hospitalisation
Mills G. et al, (2024), EUROPEAN RESPIRATORY JOURNAL, 64
Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy.
Coleman JA. et al, (2024), Front Pharmacol, 15
Long term effects of COVID-19 on the oral and lower airway microbiota
Headley DADL. et al, (2024), EUROPEAN RESPIRATORY JOURNAL, 64
Physical performance 5 and 12 months after hospital-discharge in CCVID-19 survivors
Baldwin MM. et al, (2024), EUROPEAN RESPIRATORY JOURNAL, 64
Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury.
Taquet M. et al, (2024), Brain Commun, 6
Quantitative susceptibility mapping at 7 T in COVID-19: brainstem effects and outcome associations (oct, awae332,2024)
Rua C. et al, (2024), BRAIN, 148, e3 - e3
Balancing the value and risk of exercise-based therapy post-COVID-19: a narrative review.
Singh SJ. et al, (2023), Eur Respir Rev, 32
Synbiotics in post-acute COVID-19 syndrome-a potential new treatment framework?
Raman B. and Ramasamy MN., (2023), Lancet Infect Dis
Long COVID research: an update from the PHOSP-COVID Scientific Summit.
Brightling CE. et al, (2023), Lancet Respir Med, 11, e93 - e94
Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study.
C-MORE/PHOSP-COVID Collaborative Group None., (2023), Lancet Respir Med, 11, 1003 - 1019
Personalizing Apical Hypertrophic Cardiomyopathy Diagnosis: A Major Step Forward, but Challenges Remain.
Raman B., (2023), JACC Cardiovasc Imaging
Erratum for: Lung Abnormalities Detected with Hyperpolarized 129Xe MRI in Patients with Long COVID.
Grist JT. et al, (2023), Radiology, 309
Mechanisms and prognostic impact of myocardial ischaemia in hypertrophic cardiomyopathy.
Coleman JA. et al, (2023), Int J Cardiovasc Imaging, 39, 1979 - 1996
Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization.
Taquet M. et al, (2023), Nat Med
Novel insights into diminished cardiac reserve in non-obstructive hypertrophic cardiomyopathy from four-dimensional flow cardiac magnetic resonance component analysis.
Ashkir Z. et al, (2023), Eur Heart J Cardiovasc Imaging, 24, 1192 - 1200
Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study.
Jackson C. et al, (2023), Lancet Respir Med, 11, 673 - 684
Rationale and design of a randomised trial of trientine in patients with hypertrophic cardiomyopathy.
Farrant J. et al, (2023), Heart, 109, 1175 - 1182
Prevalence of swallow, communication, voice and cognitive compromise following hospitalisation for COVID-19: the PHOSP-COVID analysis.
Dawson C. et al, (2023), BMJ Open Respir Res, 10
Liver disease is a significant risk factor for cardiovascular outcomes - A UK Biobank study.
Roca-Fernandez A. et al, (2023), J Hepatol
Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls.
Zheng B. et al, (2023), Lancet Reg Health Eur, 29
Left ventricular anatomy in obstructive hypertrophic cardiomyopathy: beyond basal septal hypertrophy.
Hermida U. et al, (2023), Eur Heart J Cardiovasc Imaging, 24, 807 - 818
Assessment of Cardiac Energy Metabolism, Function, and Physiology in Patients With Heart Failure Taking Empagliflozin: The Randomized, Controlled EMPA-VISION Trial.
Hundertmark MJ. et al, (2023), Circulation, 147, 1654 - 1669
Cohort Profile: Post-hospitalisation COVID-19 study (PHOSP-COVID)
Elneima O. et al, (2023)
Efficacy and tolerability of an endogenous metabolic modulator (AXA1125) in fatigue-predominant long COVID: a single-centre, double-blind, randomised controlled phase 2a pilot study.
Finnigan LEM. et al, (2023), EClinicalMedicine, 59
Myocardial Injury on CMR in Patients With COVID-19 and Suspected Cardiac Involvement.
Vidula MK. et al, (2023), JACC Cardiovasc Imaging, 16, 609 - 624
3-Dimensional Strain Analysis of Hypertrophic Cardiomyopathy: Insights From the NHLBI International HCM Registry.
Heydari B. et al, (2023), JACC Cardiovasc Imaging, 16, 478 - 491
Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study.
McAuley HJC. et al, (2023), EClinicalMedicine, 57
Implementable Deep Learning for Multi-sequence Proton MRI Lung Segmentation: A Multi-center, Multi-vendor, and Multi-disease Study.
Astley JR. et al, (2023), J Magn Reson Imaging
ABNORMAL SKELETAL METABOLISM BUT NOT CARDIAC DYSFUNCTION AS A CAUSE FOR FATIGUE POST COVID-19
Cassar MP. et al, (2023), JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 81, 1397 - 1397
Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization
Taquet M. et al, (2023), NATURE MEDICINE
Acute changes in myocardial tissue characteristics during hospitalization in patients with COVID-19.
Shanmuganathan M. et al, (2023), Front Cardiovasc Med, 10
Characteristics and risk factors for post-COVID-19 breathlessness after hospitalisation for COVID-19.
Daines L. et al, (2023), ERJ Open Res, 9
Differentiating left ventricular remodelling in aortic stenosis from systemic hypertension and impact of surgical replacement
Mahmod M. et al, (2023)
Editorial: Post-COVID-19 cardiovascular sequelae.
Condurache D-G. et al, (2023), Front Cardiovasc Med, 10
Efficacy and Tolerability of AXA1125, an Endogenous Metabolic Modulator Composition, in Fatigue-predominant Long COVID: A Randomized, Double-blind, Placebo-controlled Study
Finnigan L. et al, (2023), AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 207
IMPAIRED STRESS MYOCARDIAL OXYGENATION PRECEDES CONTRACTILE ABNORMALITIES IN THREE MODELS OF CARDIAC HYPERTROPHY: INSIGHTS FROM A NOVEL OXYGEN SENSITIVE CARDIAC MAGNETIC RESONANCE APPROACH
Akhtar MA. et al, (2023), HEART, 109, A8 - A9
LIVER DISEASE ACTIVITY IS A SIGNIFICANT RISK FACTOR FOR CARDIOVASCULAR OUTCOMES -A PROSPECTIVE ANALYSIS OF 33,616 INDIVIDUALS FROM THE UK BIOBANK
Roca-Fernandez A. et al, (2023), GASTROENTEROLOGY, 164, S72 - S73
Myocardial structure and function assessed by cardiac magnetic resonance in adolescents with perinatal-acquired HIV infection taking antiretroviral therapy
Majonga E. et al, (2023), BMJ GLOBAL HEALTH, 8, A7 - A7
One year health outcomes associated with systemic corticosteroids for COVID-19: a longitudinal cohort study
Leavy O. et al, (2023)
Persistence of inflammatory and vascular mediators 5 months after hospitalization with COVID-19 infection.
Melhorn J. et al, (2023), Front Med (Lausanne), 10
SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination.
Liew F. et al, (2023), EBioMedicine, 87
Subclinical Flow Inefficiencies in Non-Obstructive Hypertrophic Cardiomyopathy Subgroups Revealed by 4D Flow Cardiovascular Magnetic Resonance
Pola K. et al, (2023), CIRCULATION, 148
Cardiovascular disease and mortality sequelae of COVID-19 in the UK Biobank.
Raisi-Estabragh Z. et al, (2022), Heart, 109, 119 - 126
Multi-organ imaging demonstrates the heart-brain-liver axis in UK Biobank participants.
McCracken C. et al, (2022), Nat Commun, 13
Device-assessed sleep and physical activity in individuals recovering from a hospital admission for COVID-19: a multicentre study
Plekhanova T. et al, (2022), International Journal of Behavioral Nutrition and Physical Activity, 19
Differing Impact of Preterm Birth on the Right and Left Atria in Adulthood.
Schuermans A. et al, (2022), J Am Heart Assoc
Residual Lung Abnormalities Following COVID-19 Hospitalization: Interim Analysis of the UKILD Post-COVID Study.
Stewart I. et al, (2022), Am J Respir Crit Care Med
Long COVID: mechanisms, risk factors and recovery.
Astin R. et al, (2022), Exp Physiol
Altered lung physiology in two cohorts post COVID-19 infection as assessed using computed cardiopulmonography.
Magor-Elliott SRM. et al, (2022), J Appl Physiol (1985)
Role of Trientine in Hypertrophic Cardiomyopathy: A Review of Mechanistic Aspects.
Ramli FF. et al, (2022), Pharmaceuticals (Basel), 15
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study.
PHOSP-COVID Collaborative Group None., (2022), Lancet Respir Med, 10, 761 - 775
Associations between moderate alcohol consumption, brain iron, and cognition in UK Biobank participants: Observational and mendelian randomization analyses.
Topiwala A. et al, (2022), PLoS Med, 19
Right ventricular function declines prior to left ventricular ejection fraction in hypertrophic cardiomyopathy.
Mahmod M. et al, (2022), J Cardiovasc Magn Reson, 24
Lung Abnormalities Depicted with Hyperpolarized Xenon MRI in Patients with Long COVID.
Grist JT. et al, (2022), Radiology
Joint patient and clinician priority setting to identify 10 key research questions regarding the long-term sequelae of COVID-19.
Houchen-Wolloff L. et al, (2022), Thorax
Divergent trajectories of antiviral memory after SARS-CoV-2 infection.
Tomic A. et al, (2022), Nat Commun, 13
Postpartum blood pressure self-management following hypertensive pregnancy: protocol of the Physician Optimised Post-partum Hypertension Treatment (POP-HT) trial.
Kitt J. et al, (2022), BMJ Open, 12
Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus.
Raman B. et al, (2022), Eur Heart J
Post-Vaccine Myocarditis: A Risk Worth the Reward?
Raman B. and Neubauer S., (2022), Radiology
ASSOCIATION OF MRI-DERIVED LIVER BIOMARKERS WITH CARDIOVASCULAR RISK FACTORS, OUTCOMES, AND ALL-CAUSE MORTALITY-A PROSPECTIVE ANALYSIS OF 33,616 INDIVIDUALS FROM THE UK BIOBANK COHORT
Roca-Fernandez A. et al, (2022), HEPATOLOGY, 76, S727 - S728
Cardiopulmonary Assessment of COVID-19 Survivors Stratified by Acute Disease Severity and Post-Acute Symptoms
Szekely Y. et al, (2022), CIRCULATION, 146
Comprehensive clinical assessment identifies specific neurocognitive deficits in working-age patients with long-COVID.
Holdsworth DA. et al, (2022), PLoS One, 17
Four-dimensional flow cardiac magnetic resonance assessment of left ventricular diastolic function.
Ashkir Z. et al, (2022), Front Cardiovasc Med, 9
NOVEL INSIGHTS INTO DIMINISHED CARDIAC RESERVE IN HYPERTROPHIC CARDIOMYOPATHY FROM 4D FLOW CMR COMPONENT ANALYSIS
Ashkir Z. et al, (2022), HEART, 108, A3 - A4
Persistence of inflammatory and vascular damage mediators 5 months after acute COVID-19
Petousi N. et al, (2022), EUROPEAN RESPIRATORY JOURNAL, 60
The effects of sleep disturbance on dyspnoea and impaired lung function following COVID-19 hospitalisation: a prospective multi-centre cohort study
Jackson C. et al, (2022)
Long-term clinical outcomes in patients with a working diagnosis of myocardial infarction with non-obstructed coronary arteries (MINOCA) assessed by cardiovascular magnetic resonance imaging.
Ananthakrishna R. et al, (2021), Int J Cardiol
Association Between Sarcomeric Variants in Hypertrophic Cardiomyopathy and Myocardial Oxygenation: Insights From a Novel Oxygen-Sensitive Cardiovascular Magnetic Resonance Approach.
Raman B. et al, (2021), Circulation, 144, 1656 - 1658
HEALTHIER CMR PHENOTYPES ARE LINKED TO FAVOURABLE BRAIN MRI STRUCTURE AND FUNCTION METRICS IN THE UK BIOBANK
McCracken C. et al, (2021), HEART, 107, A4 - A5
Maximal Wall Thickness Measurement in Hypertrophic Cardiomyopathy: Biomarker Variability and its Impact on Clinical Care.
Captur G. et al, (2021), JACC Cardiovasc Imaging, 14, 2123 - 2134
Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study.
Evans RA. et al, (2021), Lancet Respir Med, 9, 1275 - 1287
Symptom Persistence Despite Improvement in Cardiopulmonary Health - Insights from longitudinal CMR, CPET and lung function testing post-COVID-19.
Cassar MP. et al, (2021), EClinicalMedicine
Incremental value of left atrial booster and reservoir strain in predicting atrial fibrillation in patients with hypertrophic cardiomyopathy: a cardiovascular magnetic resonance study.
Raman B. et al, (2021), J Cardiovasc Magn Reson, 23
Hyperpolarized 129Xe MRI Abnormalities in Dyspneic Patients 3 Months after COVID-19 Pneumonia: Preliminary Results.
Grist JT. et al, (2021), Radiology, 301, E353 - E360
Longitudinal trajectory of cardiac magnetic resonance and cardiopulmonary exercise testing findings in moderate to severe COVID-19 and association with symptoms
Cassar MP. et al, (2021), EUROPEAN HEART JOURNAL, 42, 238 - 238
Late Breaking Abstract - Breathlessness post COVID-19 despite improvement in cardiopulmonary health
Cassar MP. et al, (2021), EUROPEAN RESPIRATORY JOURNAL, 58
Association of Preterm Birth With Myocardial Fibrosis and Diastolic Dysfunction in Young Adulthood.
Lewandowski AJ. et al, (2021), J Am Coll Cardiol, 78, 683 - 692
Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern.
Skelly DT. et al, (2021), Nat Commun, 12
Adapting the UK Biobank brain imaging protocol and analysis pipeline for the C-MORE multi-organ study of COVID-19 survivors
Griffanti L. et al, (2021)
Adverse cardiovascular magnetic resonance phenotypes are associated with greater likelihood of incident coronavirus disease 2019: findings from the UK Biobank.
Raisi-Estabragh Z. et al, (2021), Aging Clin Exp Res, 33, 1133 - 1144
Adapting the UK Biobank Brain Imaging Protocol and Analysis Pipeline for the C-MORE Multi-Organ Study of COVID-19 Survivors.
Griffanti L. et al, (2021), Front Neurol, 12
Adapting the UK Biobank Brain Imaging Protocol and Analysis Pipeline for the C-MORE Multi-Organ Study of COVID-19 Survivors.
Griffanti L. et al, (2021), Front Neurol, 12
Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge.
Raman B. et al, (2021), EClinicalMedicine, 31
Predicting the Future From Scars of the Past.
Raman B. and Kramer CM., (2020), JACC Cardiovasc Imaging
Magnetic resonance imaging
HESS A. et al, (2020)
Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge
Raman B. et al, (2020)
Myocardial Deformation Analysis in Hypertrophic Cardiomyopathy With Sarcomere Mutations: Insights From 2,221 Patients Within the NHLBI-HCM Registry
Heydari B. et al, (2020), CIRCULATION, 142
British Cardiovascular Society Young Investigator Award 2019.
Page DJ. et al, (2019), Heart, 105, 1841 - 1842
Impaired Stress Myocardial Oxygenation and Not Perfusion Reserve is Associated With Arrhythmic Risk in Hypertrophic Cardiomyopathy: Insights From a Novel Oxygen Sensitive Cardiac Magnetic Resonance Approach
Raman B. et al, (2019), CIRCULATION, 140
Histological Evidence for Impaired Myocardial Perfusion Reserve in Severe Aortic Stenosis.
Mahmod M. et al, (2019), JACC Cardiovasc Imaging, 12, 2276 - 2278
Blunted stress myocardial oxygenation and not myocardial perfusion reserve is associated with arrhythmic risk in hypertrophic cardiomyopathy
Raman B. et al, (2019), EUROPEAN HEART JOURNAL, 40, 1360 - 1360
Localized rest and stress human cardiac creatine kinase reaction kinetics at 3 T.
Clarke WT. et al, (2019), NMR Biomed, 32
Identification of Myocardial Disarray in Patients With Hypertrophic Cardiomyopathy and Ventricular Arrhythmias.
Ariga R. et al, (2019), J Am Coll Cardiol, 73, 2493 - 2502
Measuring inorganic phosphate and intracellular pH in the healthy and hypertrophic cardiomyopathy hearts by in vivo 7T 31P-cardiovascular magnetic resonance spectroscopy.
Valkovič L. et al, (2019), J Cardiovasc Magn Reson, 21
Progression of myocardial fibrosis in hypertrophic cardiomyopathy: mechanisms and clinical implications.
Raman B. et al, (2019), Eur Heart J Cardiovasc Imaging, 20, 157 - 167
ENDOTHELIAL LOSS AS A CAUSE OF IMPAIRED MYOCARDIAL PERFUSION RESERVE IN SEVERE AORTIC STENOSIS
Chan K. et al, (2019), HEART, 105, A100 - A101
ENDOTHELIAL LOSS AS A CAUSE OF IMPAIRED MYOCARDIAL PERFUSION RESERVE ON CMR IN SEVERE AORTIC STENOSIS
Chan K. et al, (2019), HEART, 105, A17 - A18
IMPAIRED STRESS-INDUCED OXYGENATION IN HYPERTROPHIC CARDIOMYOPATHY IS ASSOCIATED WITH AN INCREASED RISK OF VENTRICULAR ARRHYTHMIA
Raman B. et al, (2019), HEART, 105, A18 - A20

More publications

Cookies on this website

portrait

Research groups

DPhil Opportunities Available

Colleges

Websites

Betty Raman

Recent publications